FDA Approved Medical Products for:

Hereditary angioedema

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name C1 esterase inhibitor (human)
Trade Name
(Manufacturer Name)
Cinryze®
(ViroPharma Incorporated)
Indication
The FDA has approved this product to be used in this manner.
Routine prophylaxis against angioedema attacks in patients with Hereditary Angioedema (HAE)
More Information about this product Drug Information Portal

Generic Name Icatibant
Trade Name
(Manufacturer Name)
Firazyr
(Shire Orphan Therapies)
Indication
The FDA has approved this product to be used in this manner.
Treatment of acute attacks of hereditary angioedema in adults 18 years of age and older
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Ecallantide
Trade Name
(Manufacturer Name)
Kalbitor
(Dyax Corp)
Indication
The FDA has approved this product to be used in this manner.
Treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older
More Information about this product Drug Information Portal

Generic Name C1-esterase inhibitor (recombinant)
Trade Name
(Manufacturer Name)
Ruconest
(Pharming N.V.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of acute attacks of hereditary angioedema (HAE) in adult and adolescent patients.
More Information about this product Drug Information Portal